Log in to save to my catalogue

Cerebral Amyloidoses: Molecular Pathways and Therapeutic Challenges

Cerebral Amyloidoses: Molecular Pathways and Therapeutic Challenges

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68637787

Cerebral Amyloidoses: Molecular Pathways and Therapeutic Challenges

About this item

Full title

Cerebral Amyloidoses: Molecular Pathways and Therapeutic Challenges

Publisher

Schiphol: Bentham Science Publishers Ltd

Journal title

Current medicinal chemistry, 2006-07, Vol.13 (16), p.1903-1913

Language

English

Formats

Publication information

Publisher

Schiphol: Bentham Science Publishers Ltd

More information

Scope and Contents

Contents

Alzheimer disease (AD) and Creutzfeldt-Jakob disease (CJD) are sporadic and genetic neurodegenerative conditions characterized by brain accumulation and deposition of protein aggregates. In AD, the key pathogenic event is linked to the formation of a 4-kDa amyloid β (Aβ) peptide, generated by sequential cleavages of the amyloid precursor protein (A...

Alternative Titles

Full title

Cerebral Amyloidoses: Molecular Pathways and Therapeutic Challenges

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_68637787

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68637787

Other Identifiers

ISSN

0929-8673

E-ISSN

1875-533X

DOI

10.2174/092986706777585022

How to access this item